Lei Li, Yuan Jiali, Yang Qingqing, Tu Qiuxia, Yu Haijun, Chu Liangzhao, Tang Lei, Zhang Chunlin
Engineering Research Center for Molecular Medicine, School of Basic Medical Science, Guizhou Medical University Guiyang 550025 China.
Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University Guiyang Guizhou China.
RSC Adv. 2024 May 7;14(21):14934-14941. doi: 10.1039/d4ra02336f. eCollection 2024 May 2.
Ferroptosis, characterized by elevated iron levels and lipid peroxidation (LPO), is a recently identified regulatory mechanism of cell death. Its substantial involvement in ischemic tissue injury, neurodegenerative disorders, and cancer positions ferroptosis inhibition as a promising strategy for managing these diverse diseases. In this study, we introduce curcumin-polydopamine nanoparticles (Cur-PDA NPs) as an innovative ferroptosis inhibitor. Cur-PDA NPs demonstrate remarkable efficacy in chelating both Fe and Fe along with scavenging free radicals. Cur-PDA NPs were found to efficiently mitigate reactive oxygen species, reduce Fe accumulation, suppress LPO, and rejuvenate mitochondrial function in PC12 cells. Thus, these NPs can act as potent therapeutic agents against ferroptosis, primarily iron chelation and reduction of oxidative stress.
铁死亡以铁水平升高和脂质过氧化(LPO)为特征,是最近发现的一种细胞死亡调节机制。它在缺血性组织损伤、神经退行性疾病和癌症中大量参与,使得抑制铁死亡成为治疗这些多种疾病的一种有前景的策略。在本研究中,我们引入姜黄素-聚多巴胺纳米颗粒(Cur-PDA NPs)作为一种创新的铁死亡抑制剂。Cur-PDA NPs在螯合Fe和Fe以及清除自由基方面表现出显著功效。研究发现Cur-PDA NPs能有效减轻活性氧,减少铁积累,抑制LPO,并恢复PC12细胞的线粒体功能。因此,这些纳米颗粒可作为对抗铁死亡的有效治疗剂,主要通过铁螯合和降低氧化应激来实现。